STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy

Detalles Bibliográficos
Autores principales: Gerthofer, Valeria, Scheiter, Alexander, Lüke, Florian, Keil, Felix, Utpatel, Kirsten, Pöhmerer, Laura-Maria-Giovanna, Seitz, Johannes, Niessen, Christoph, Ignatov, Atanas, Dietmaier, Wolfgang, Calvisi, Diego F., Evert, Matthias, Ortmann, Olaf, Seitz, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462007/
https://www.ncbi.nlm.nih.gov/pubmed/34568722
http://dx.doi.org/10.1200/PO.21.00184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462007/
https://www.ncbi.nlm.nih.gov/pubmed/34568722
http://dx.doi.org/10.1200/PO.21.00184

Ejemplares similares